0
Kamada Ltd. Banner Image

Kamada Ltd.

  • Ticker KMDA
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Kamada Ltd. Logo Image
  • 201-500 Employees
  • Based in Rehovot, Israel
Kamada Ltd. (“the Company”) is a commercial stage plasma-derived biopharmaceutical company focused on orphan indications, with an existing marketed product portfolio and a late-stage product pipeline. The Company uses its proprietary platform technology and know-how for the extraction and purification of proteins from human plasma to produce Alpha-1 Antitrypsin (AAT) in a highly-purifiedMore, liquid form, as well as other plasma-derived immune globulins. The Company’s flagship product is GLASSIA®, the first liquid, ready-to-use, intravenous plasma-derived AAT product approved by the U.S. FDA. The Company markets GLASSIA in the U.S. through a strategic partnership with Takeda Pharmaceuticals Company Limited and in other countries through local distributors.
Kamada Ltd.

Most Recent Annual Report

Kamada Ltd.
MOST RECENT 2021 Annual Report

Older/Archived Annual Reports